Laura A. Lebherz

Laura A. Lebherz serves as a Contract Specialist at the Naval Medical Logistics Command (N62645), where she plays a critical role in procuring mission-critical medical equipment and diagnostic systems that sustain the readiness of U.S. Navy and Marine Corps medical forces worldwide. She manages the full lifecycle of acquisitions for high-precision analytical instruments, surgical tools, and in-vitro diagnostic substances, ensuring compliance with DoD acquisition regulations and operational readiness requirements. Her work directly supports the Command’s strategic priorities in modernizing point-of-care diagnostics and sustaining a resilient medical logistics pipeline across global theaters. Lebherz collaborates with a diverse range of vendors, including manufacturers of laboratory and medical instrumentation, as well as specialized technical service providers delivering research, development, and calibration support. While no single contractor dominates her portfolio, she consistently engages with firms possessing ISO 13485 certification, FDA-registered facilities, and defense supply chain credentials. Her contracting approach emphasizes technical compliance, performance-based outcomes, and long-term sustainment capabilities over short-term cost savings. Her procurement activity reflects a strong preference for full and open competition, with 100% of her acquisitions conducted without set-asides. This indicates a focus on technical superiority and mission-critical performance rather than socioeconomic preferences, though she remains compliant with all applicable small business regulations and may incorporate small business subcontracting where strategically advantageous. Lebherz specializes in NAICS 334516 (analytical laboratory instruments), 339112 (surgical and medical instruments), and 541990 (professional scientific services), demonstrating deep expertise in procuring diagnostic systems, sterile surgical tools, and life sciences R&D support. Her domain knowledge spans clinical laboratory automation, point-of-care testing platforms, and sterilization-compliant instrumentation, making her a key liaison between operational medical requirements and advanced manufacturing capabilities.